GlassScriptPhysician profile
Krista Mast
NPI 1568019750
$5,704.72
in general payments reported to CMS, 2019-2025
36 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,806 · 2022: $1,856 · 2023: $759 · 2024: $762 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,104.87 | 2021-2025 | |
| Novo Nordisk INC | $775.53 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $471.06 | 2021-2023 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.62 | 2021-2025 | Jardiance, Ofev |
| Sanofi-Aventis U.S. LLC | $271.93 | 2021-2024 | |
| Lilly USA, LLC | $268.32 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $232.34 | 2021-2022 | |
| Abbott Laboratories | $208.55 | 2021-2025 | Freestyle Libre 2 |
| Astellas Pharma US INC | $199.53 | 2021-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $187.81 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $179.23 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $174.80 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $167.01 | 2021-2024 | Xifaxan |
| Pfizer INC. | $157.95 | 2021-2024 | |
| Exact Sciences Corporation | $151.87 | 2023-2024 | Cologuard Collection Kit |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $125.56 | 2021 | |
| Amarin Pharma, INC. | $105.42 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $98.87 | 2024 | Keveyis, Gvoke Hypopen |
| Sanofi Pasteur INC. | $70.47 | 2022-2024 | |
| Amgen INC. | $49.02 | 2023-2025 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $44.37 | 2021-2022 | |
| Dexcom, INC. | $38.65 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $36.15 | 2024-2025 | Voquezna |
| Seqirus USA INC | $29.09 | 2021-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Corcept Therapeutics | $22.29 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $20.44 | 2023 | Prehevbrio |
| Otsuka America Pharmaceutical, INC. | $18.60 | 2023 | Rexulti |
| Shield Therapeutics INC | $18.10 | 2023 | Accrufer |
| Optinose US, INC. | $17.93 | 2024 | |
| Inspire Medical Systems, INC. | $16.56 | 2024 | Inspire |
| Hologic Sales and Service, LLC | $15.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.90 | 2021 | |
| Dynavax Technologies Corporation | $13.34 | 2024 | Heplisav-B |
| Almatica Pharma LLC | $12.25 | 2022 | |
| Bausch Health US, LLC | $11.94 | 2022 | |
| Merck Sharp & Dohme LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Mast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.